These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36438496)

  • 1. Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin.
    Reissig F; Zarschler K; Novy Z; Petrik M; Bendova K; Kurfurstova D; Bouchal J; Ludik MC; Brandt F; Kopka K; Khoylou M; Pietzsch HJ; Hajduch M; Mamat C
    Theranostics; 2022; 12(17):7203-7215. PubMed ID: 36438496
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy.
    Umbricht CA; Benešová M; Schibli R; Müller C
    Mol Pharm; 2018 Jun; 15(6):2297-2306. PubMed ID: 29684274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation of a New Series of Albumin-Binding
    Boinapally S; Alati S; Jiang Z; Yan Y; Lisok A; Singh R; Lofland G; Minn I; Hobbs RF; Pomper MG; Banerjee SR
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile.
    Benešová M; Umbricht CA; Schibli R; Müller C
    Mol Pharm; 2018 Mar; 15(3):934-946. PubMed ID: 29400475
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Kuo HT; Lin KS; Zhang Z; Uribe CF; Merkens H; Zhang C; Bénard F
    J Nucl Med; 2021 Apr; 62(4):521-527. PubMed ID: 32859704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for
    Umbricht CA; Benešová M; Hasler R; Schibli R; van der Meulen NP; Müller C
    Mol Pharm; 2018 Dec; 15(12):5556-5564. PubMed ID: 30376344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotheranostics Using a Novel
    Iikuni S; Tarumizu Y; Nakashima K; Higaki Y; Ichikawa H; Watanabe H; Ono M
    J Med Chem; 2021 Sep; 64(18):13429-13438. PubMed ID: 34477385
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity.
    Deberle LM; Benešová M; Umbricht CA; Borgna F; Büchler M; Zhernosekov K; Schibli R; Müller C
    Theranostics; 2020; 10(4):1678-1693. PubMed ID: 32042329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations Using Albumin Binders to Modify the Tissue Distribution Profile of Radiopharmaceuticals Exemplified with Folate Radioconjugates.
    Busslinger SD; Becker AE; Vaccarin C; Deberle LM; Renz ML; Groehn V; Schibli R; Müller C
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-affinity-pharmacokinetics relationships of
    Yamaguchi K; Kazuta N; Tsuchihashi S; Watanabe H; Ono M
    Nucl Med Biol; 2024 Aug; 138-139():108945. PubMed ID: 39153354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of
    Bobba KN; Bidkar AP; Meher N; Fong C; Wadhwa A; Dhrona S; Sorlin A; Bidlingmaier S; Shuere B; He J; Wilson DM; Liu B; Seo Y; VanBrocklin HF; Flavell RR
    J Nucl Med; 2023 Jul; 64(7):1076-1082. PubMed ID: 37201957
    [No Abstract]   [Full Text] [Related]  

  • 12. Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors.
    Kelly J; Amor-Coarasa A; Ponnala S; Nikolopoulou A; Williams C; Schlyer D; Zhao Y; Kim D; Babich JW
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1841-1851. PubMed ID: 29623376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands.
    Kazuta N; Tsuchihashi S; Watanabe H; Ono M
    Ann Nucl Med; 2024 Jul; 38(7):574-583. PubMed ID: 38676906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Application of Albumin-Binding [
    Borgna F; Deberle LM; Cohrs S; Schibli R; Müller C
    Mol Pharm; 2020 Jun; 17(6):2044-2053. PubMed ID: 32383887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer.
    Kelly JM; Amor-Coarasa A; Nikolopoulou A; Wüstemann T; Barelli P; Kim D; Williams C; Zheng X; Bi C; Hu B; Warren JD; Hage DS; DiMagno SG; Babich JW
    J Nucl Med; 2017 Sep; 58(9):1442-1449. PubMed ID: 28450562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lys-urea-Aad, Lys-urea-Cmc and Lys-urea-Cms as potential pharmacophores for the design of PSMA-targeted radioligands to reduce off-target uptake in kidneys and salivary glands.
    Kuo HT; Zhang Z; Zhang C; Merkens H; Tan R; Wong AAWL; Uribe CF; Bénard F; Lin KS
    Theranostics; 2023; 13(13):4559-4573. PubMed ID: 37649602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using
    Yusufi N; Wurzer A; Herz M; D'Alessandria C; Feuerecker B; Weber W; Wester HJ; Nekolla S; Eiber M
    J Nucl Med; 2021 Aug; 62(8):1106-1111. PubMed ID: 33443072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Dose of
    Kelly JM; Amor-Coarasa A; Ponnala S; Nikolopoulou A; Williams C; Thiele NA; Schlyer D; Wilson JJ; DiMagno SG; Babich JW
    J Nucl Med; 2019 May; 60(5):649-655. PubMed ID: 30413660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer.
    Schatz CA; Zitzmann-Kolbe S; Moen I; Klotz M; Nair S; Stargard S; Bjerke RM; Wickstrøm Biseth K; Feng YZ; Indrevoll B; Cruciani V; Karlsson J; Haendler B; Nielsen CH; Alfsen MZ; Hammer S; Hennekes H; Cuthbertson A; Hagemann UB; Larsen Å
    Clin Cancer Res; 2024 Jun; 30(11):2531-2544. PubMed ID: 38593212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Evaluation of Novel Albumin-Binding Folate Radioconjugates: Systematic Approach of Varying the Linker Entities.
    Benešová M; Guzik P; Deberle LM; Busslinger SD; Landolt T; Schibli R; Müller C
    Mol Pharm; 2022 Mar; 19(3):963-973. PubMed ID: 35192367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.